Press release: Ncardia Appoints Andy Holt as Chief Commercial Officer

iPSC technology leader taps industry veteran to drive growth in cell therapy and drug discovery marketsLEIDEN, The Netherlands--(BUSINESS WIRE)--Ncardia, the leader in developing stem cell-based solutions for drug discovery and cell therapy, announced today the appointment of Andy Holt as Chief Commercial Officer.Mr. Holt brings more than fifteen years of experience in cell and gene therapy to his